首页|甲氨蝶呤联合吗替麦考酚酯治疗系统性红斑狼疮的效果

甲氨蝶呤联合吗替麦考酚酯治疗系统性红斑狼疮的效果

扫码查看
目的:探讨甲氨蝶呤联合吗替麦考酚酯对系统性红斑狼疮的治疗效果.方法:选取抚州市第一人民医院在 2022 年 9 月—2023 年 8 月收治的系统性红斑狼疮患者共 60 例作为研究对象.根据随机数字表法将患者分为观察组(n=30)和对照组(n=30).对照组口服吗替麦考酚酯胶囊,观察组在对照组的基础上口服甲氨蝶呤片,持续治疗时间为 3 个月.比较两组临床疗效、治疗前及治疗 3 个月后的症状改善程度、免疫学指标[补体C3、C4 及免疫球蛋白(IgG、IgA、IgM)]、不良反应(恶心、腹泻、发热、感染)发生情况.结果:治疗 3 个月后,观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05).治疗 3 个月后,两组系统性红斑狼疮疾病活动性指数(SLEDAI)和系统狼疮活动性测定(SLAM)评分均有所下降,且观察组均低于对照组,差异均有统计学意义(P<0.05).治疗 3 个月后,两组补体C3、C4 水平均较治疗前有所上升,且观察组均高于对照组,差异均有统计学意义(P<0.05);两组IgG、IgA、IgM水平则均有所下降,且观察组均低于对照组,差异均有统计学意义(P<0.05).两组不良反应总发生率比较,差异无统计学意义(P>0.05).结论:甲氨蝶呤联合吗替麦考酚酯能够有效改善系统性红斑狼疮患者的临床症状及免疫功能,临床价值显著.
Effect of Methotrexate Combined with Mycophenolate Mofetil in the Treatment of Systemic Lupus Erythematosus
Objective:To explore the therapeutic effect of combination of Methotrexate and Mycophenolate Mofetil on systemic lupus erythematosus.Method:A total of sixty patients with systemic lupus erythematosus in First People's Hospital of Fuzhou were regarded as the study subjects from September 2022 to August 2023.According to the random number table method,they were divided into observation group(n=30)and control group(n=30).The control group was treated with Mycophenolate Mofetil Capsules orally,and the observation group took Methotrexate Tablets orally on the basis of the control group,and the treatment lasted for 3 months.Clinical efficacy,and symptom improvement degree,immunological indicators[complements C3 and C4,immunoglobulins(IgG,IgA,IgM)]before treatment and at 3 months after treatment and incidence of adverse reactions(nausea,diarrhea,fever,infection)between two groups were compared.Result:After 3 months of treatment,the total effective rate of the observation group was higher than that of the control group,the difference was statistically significant(P<0.05).After 3 months of treatment,the scores of systemic lupus erythematosus disease activity index(SLEDAI)and systemic lupus activity measure(SLAM)in the two groups were declined,and those in observation group were lower than those in control group,the differences were statistically significant(P<0.05).After 3 months of treatment,the levels of C3 and C4 were risen in both groups compared to those before treatment,and those in observation group were higher than those in control group,the differences were statistically significant(P<0.05);the levels of IgG,IgA and IgM were reduced in both groups,and those in observation group were lower than those in control group,the differences were statistically significant(P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion:Methotrexate combined with Mycophenolate Mofetil can effectively improve the clinical symptoms and immune function of patients with systemic lupus erythematosus,with a significant clinical value.

MethotrexateMycophenolate MofetilSystemic lupus erythematosus

黄洁、单皆、张嘉骐、郑超

展开 >

抚州市第一人民医院风湿免疫科 江西 抚州 344000

抚州市第一人民医院肾内科 江西 抚州 344000

甲氨蝶呤 吗替麦考酚酯 系统性红斑狼疮

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(26)